Cytovia Therapeutics
Cytovia Therapeutics is developing a Dual-Acting Natural Killer Immunotherapy Against SARS CoV2, the drug responsible for Covid-19 (in collaboration with Macromoltek)
Rankings by
Национальный рейтинг415th
in United States Региональный рейтинг471st
in North America and Caribbean Глобальный рейтинг1130th
worldwide